ALB
ALB
Albemarle CorporationIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $1.43B ▲ | $154.48M ▲ | $-414.18M ▼ | -29% ▼ | $-3.87 ▼ | $211.96M ▲ |
| Q3-2025 | $1.31B ▼ | $148.07M ▲ | $-160.69M ▼ | -12.29% ▼ | $-1.72 ▼ | $134.03M ▼ |
| Q2-2025 | $1.33B ▲ | $143.13M ▲ | $22.9M ▼ | 1.72% ▼ | $-0.16 ▼ | $222.47M ▲ |
| Q1-2025 | $1.08B ▼ | $136.86M ▼ | $41.35M ▼ | 3.84% ▼ | $-0 ▼ | $181.19M ▲ |
| Q4-2024 | $1.23B | $153.72M | $75.29M | 6.11% | $0.29 | $147.6M |
What's going well?
Revenue grew 9% and gross profit jumped 72%, showing the core business is recovering. Operating income turned positive after a loss last quarter, and cost control is improving.
What's concerning?
Net loss more than doubled due to large 'other' expenses and a big tax charge, which wiped out operating gains. The company remains unprofitable overall, and earnings are distorted by non-core items.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $1.62B ▼ | $16.37B ▼ | $6.59B ▼ | $9.53B ▼ |
| Q3-2025 | $1.93B ▲ | $17.15B ▼ | $6.88B ▲ | $10B ▼ |
| Q2-2025 | $1.81B ▲ | $17.29B ▲ | $6.79B ▲ | $10.24B ▲ |
| Q1-2025 | $1.52B ▲ | $17B ▲ | $6.72B ▲ | $10.03B ▲ |
| Q4-2024 | $1.19B | $16.61B | $6.41B | $9.96B |
What's financially strong about this company?
Debt is falling, inventory is being managed well, and the company has a strong equity base. Most assets are tangible, and working capital is efficient.
What are the financial risks or weaknesses?
Cash reserves are shrinking, and book value per share is down. Equity and total assets both declined this quarter, which could be a warning sign if the trend continues.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-401.76M ▼ | $388.49M ▲ | $-176.64M ▼ | $-533.02M ▼ | $-313.76M ▼ | $233.1M ▲ |
| Q3-2025 | $-147.94M ▼ | $355.6M ▲ | $-152.98M ▼ | $-90.53M ▲ | $124.93M ▼ | $223.44M ▲ |
| Q2-2025 | $35.19M ▼ | $-7.2M ▼ | $362.92M ▲ | $-90.63M ▲ | $288.32M ▼ | $-126.83M ▼ |
| Q1-2025 | $49.3M ▼ | $545.38M ▲ | $-179.3M ▲ | $-120.01M ▼ | $326.28M ▲ | $362.76M ▲ |
| Q4-2024 | $85.11M | $674K | $-327.81M | $-92.88M | $-472.29M | $-355.05M |
What's strong about this company's cash flow?
ALB produces real cash from its business, with $388 million in operating cash flow and $233 million in free cash flow this quarter. The company is paying down debt and can easily cover its dividend.
What are the cash flow concerns?
Net losses are growing, and much of the cash flow boost came from working capital changes that may not last. Cash on hand fell by $314 million, which could be a warning sign if the trend continues.
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Energy Storage | $520.00M ▲ | $720.00M ▲ | $710.00M ▼ | $760.00M ▲ |
Ketjen | $230.00M ▲ | $260.00M ▲ | $250.00M ▼ | $320.00M ▲ |
Specialties | $320.00M ▲ | $350.00M ▲ | $340.00M ▼ | $350.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Albemarle Corporation's financial evolution and strategic trajectory over the past five years.
Albemarle combines a strong strategic footprint in high‑growth lithium markets with established positions in bromine and catalysts. Historically it has shown the ability to achieve very high margins and strong operating cash flow when market conditions are favorable. The company controls valuable, diversified resource assets, benefits from vertical integration and scale, and supports these with a broad patent portfolio and active R&D program. Its substantial past investments in capacity and technology, if well utilized, provide a platform for future volume growth and product differentiation.
The most recent financial data highlight significant risks. Revenue and margins have fallen sharply from their peak, and the company is now loss‑making at the bottom line. The dramatic reported shrinkage in assets, equity, cash, and debt in 2025 suggests either a major restructuring or data/measurement issues; in any case, it raises questions about current balance‑sheet strength and business scope. Albemarle remains highly exposed to volatile commodity prices, regulatory and ESG pressures on mining and chemicals, and intense competition in global lithium markets. Heavy capital spending and ambitious R&D projects add execution and funding risk, particularly during periods of weak profitability.
Albemarle’s long‑term prospects are closely tied to the global adoption of electric vehicles, grid‑scale storage, and advanced electronics—secular trends that still appear favorable for lithium and high‑purity specialty chemicals. If the company can stabilize margins, effectively ramp its new capacity, and monetize its innovation pipeline, its structural advantages could once again translate into strong financial performance. However, the path from the current downturn to a more normalized earnings and balance‑sheet profile is uncertain and likely to be bumpy, given commodity cycles and the apparent need to digest past expansion. A clear understanding of the latest official financial statements and strategic updates will be essential to gauge how Albemarle is navigating this transition.
About Albemarle Corporation
https://www.albemarle.comAlbemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $1.43B ▲ | $154.48M ▲ | $-414.18M ▼ | -29% ▼ | $-3.87 ▼ | $211.96M ▲ |
| Q3-2025 | $1.31B ▼ | $148.07M ▲ | $-160.69M ▼ | -12.29% ▼ | $-1.72 ▼ | $134.03M ▼ |
| Q2-2025 | $1.33B ▲ | $143.13M ▲ | $22.9M ▼ | 1.72% ▼ | $-0.16 ▼ | $222.47M ▲ |
| Q1-2025 | $1.08B ▼ | $136.86M ▼ | $41.35M ▼ | 3.84% ▼ | $-0 ▼ | $181.19M ▲ |
| Q4-2024 | $1.23B | $153.72M | $75.29M | 6.11% | $0.29 | $147.6M |
What's going well?
Revenue grew 9% and gross profit jumped 72%, showing the core business is recovering. Operating income turned positive after a loss last quarter, and cost control is improving.
What's concerning?
Net loss more than doubled due to large 'other' expenses and a big tax charge, which wiped out operating gains. The company remains unprofitable overall, and earnings are distorted by non-core items.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $1.62B ▼ | $16.37B ▼ | $6.59B ▼ | $9.53B ▼ |
| Q3-2025 | $1.93B ▲ | $17.15B ▼ | $6.88B ▲ | $10B ▼ |
| Q2-2025 | $1.81B ▲ | $17.29B ▲ | $6.79B ▲ | $10.24B ▲ |
| Q1-2025 | $1.52B ▲ | $17B ▲ | $6.72B ▲ | $10.03B ▲ |
| Q4-2024 | $1.19B | $16.61B | $6.41B | $9.96B |
What's financially strong about this company?
Debt is falling, inventory is being managed well, and the company has a strong equity base. Most assets are tangible, and working capital is efficient.
What are the financial risks or weaknesses?
Cash reserves are shrinking, and book value per share is down. Equity and total assets both declined this quarter, which could be a warning sign if the trend continues.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-401.76M ▼ | $388.49M ▲ | $-176.64M ▼ | $-533.02M ▼ | $-313.76M ▼ | $233.1M ▲ |
| Q3-2025 | $-147.94M ▼ | $355.6M ▲ | $-152.98M ▼ | $-90.53M ▲ | $124.93M ▼ | $223.44M ▲ |
| Q2-2025 | $35.19M ▼ | $-7.2M ▼ | $362.92M ▲ | $-90.63M ▲ | $288.32M ▼ | $-126.83M ▼ |
| Q1-2025 | $49.3M ▼ | $545.38M ▲ | $-179.3M ▲ | $-120.01M ▼ | $326.28M ▲ | $362.76M ▲ |
| Q4-2024 | $85.11M | $674K | $-327.81M | $-92.88M | $-472.29M | $-355.05M |
What's strong about this company's cash flow?
ALB produces real cash from its business, with $388 million in operating cash flow and $233 million in free cash flow this quarter. The company is paying down debt and can easily cover its dividend.
What are the cash flow concerns?
Net losses are growing, and much of the cash flow boost came from working capital changes that may not last. Cash on hand fell by $314 million, which could be a warning sign if the trend continues.
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Energy Storage | $520.00M ▲ | $720.00M ▲ | $710.00M ▼ | $760.00M ▲ |
Ketjen | $230.00M ▲ | $260.00M ▲ | $250.00M ▼ | $320.00M ▲ |
Specialties | $320.00M ▲ | $350.00M ▲ | $340.00M ▼ | $350.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Albemarle Corporation's financial evolution and strategic trajectory over the past five years.
Albemarle combines a strong strategic footprint in high‑growth lithium markets with established positions in bromine and catalysts. Historically it has shown the ability to achieve very high margins and strong operating cash flow when market conditions are favorable. The company controls valuable, diversified resource assets, benefits from vertical integration and scale, and supports these with a broad patent portfolio and active R&D program. Its substantial past investments in capacity and technology, if well utilized, provide a platform for future volume growth and product differentiation.
The most recent financial data highlight significant risks. Revenue and margins have fallen sharply from their peak, and the company is now loss‑making at the bottom line. The dramatic reported shrinkage in assets, equity, cash, and debt in 2025 suggests either a major restructuring or data/measurement issues; in any case, it raises questions about current balance‑sheet strength and business scope. Albemarle remains highly exposed to volatile commodity prices, regulatory and ESG pressures on mining and chemicals, and intense competition in global lithium markets. Heavy capital spending and ambitious R&D projects add execution and funding risk, particularly during periods of weak profitability.
Albemarle’s long‑term prospects are closely tied to the global adoption of electric vehicles, grid‑scale storage, and advanced electronics—secular trends that still appear favorable for lithium and high‑purity specialty chemicals. If the company can stabilize margins, effectively ramp its new capacity, and monetize its innovation pipeline, its structural advantages could once again translate into strong financial performance. However, the path from the current downturn to a more normalized earnings and balance‑sheet profile is uncertain and likely to be bumpy, given commodity cycles and the apparent need to digest past expansion. A clear understanding of the latest official financial statements and strategic updates will be essential to gauge how Albemarle is navigating this transition.

CEO
Jerry Kent Masters Jr.
Compensation Summary
(Year 2024)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2007-03-02 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 483
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Evercore ISI Group
In Line
B of A Securities
Buy
RBC Capital
Outperform
Citigroup
Neutral
Mizuho
Neutral
Jefferies
Buy
Grade Summary
Showing Top 6 of 18
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:14.6M
Value:$2.61B
BLACKROCK INC.
Shares:9.96M
Value:$1.78B
CAPITAL WORLD INVESTORS
Shares:8.74M
Value:$1.56B
Summary
Showing Top 3 of 1,242

